Venrock, a NYC, Boston, MA and Palo Alto, California-based technology and healthcare focused venture capital firm, closed its latest fund, at $450m.
Venrock 8 will follow a similar strategy of the last several funds, partnering with entrepreneurs to build disruptive companies with a primary focus on technology and healthcare.
The investment team currently includes:
– Nimish Shah, Alex Rosen, David Pakman, Bong Koh, Richard Kerby, Paul Dossa, Egen Atkinson, Nick Beim, and Alon Bonder in New York
– Camille Samuels, Bryan Roberts, Isaac Madan, Bob Kocher, Doug Dooley, Colin Cahill, Brian Ascher, and Racquel Bracken in Palo Alto
– Mike Tyrrell in Cambridge
Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock has invested in such companies as Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Millennium Pharma, Nest, SlideShare and Tudou, among others.
FinSMEs
27/01/2017